144 related articles for article (PubMed ID: 22166323)
1. Celebrating the death of PSA screening?
Gomella LG
Can J Urol; 2011 Dec; 18(6):5987. PubMed ID: 22166323
[No Abstract] [Full Text] [Related]
2. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
Telesca D; Etzioni R; Gulati R
Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
Loeb S; Catalona WJ
Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
[No Abstract] [Full Text] [Related]
4. Adding age and genetic risk to PSA test could improve screening for prostate cancer.
Kmietowicz Z
BMJ; 2012 Nov; 345():e7467. PubMed ID: 23131672
[No Abstract] [Full Text] [Related]
5. Screening for prostate cancer: current recommendations.
Wilson SS; Crawford ED
Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402
[TBL] [Abstract][Full Text] [Related]
6. Regular PSA screens undervalued, underutilized in prostate cancer detection.
Healthc Demand Dis Manag; 2000 May; 6(5):70-2, 65. PubMed ID: 11383016
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer options expand beyond the PSA.
Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
[No Abstract] [Full Text] [Related]
8. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
Colli JL; Amling CL
Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
[TBL] [Abstract][Full Text] [Related]
9. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
10. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later.
Pienta KJ
Urology; 2009 May; 73(5 Suppl):S11-20. PubMed ID: 19375622
[TBL] [Abstract][Full Text] [Related]
11. Is the PSA test useless?
Kirby R; Moul JW
Prostate Cancer Prostatic Dis; 2004; 7(4):271-2. PubMed ID: 15592438
[No Abstract] [Full Text] [Related]
12. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
13. Prostate-specific antigen: a new(ish) study.
Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
[No Abstract] [Full Text] [Related]
14. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
15. PSA screening.
Cohen S; Schiff S; Kelty P
Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
[No Abstract] [Full Text] [Related]
16. What is the value of screening for prostate cancer in the US?
Albertsen PC
Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
[No Abstract] [Full Text] [Related]
17. Prostate cancer: who to screen, and what the results mean.
Small EJ
Geriatrics; 1993 Dec; 48(12):28-30, 35-8. PubMed ID: 7504646
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer in the serum prostate-specific antigen era.
Humphrey PA
Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595
[No Abstract] [Full Text] [Related]
19. Abandoning isolated free PSA screenings for more comprehensive cardiovascular and cancer screening and education.
Moyad MA
Urol Nurs; 2005 Apr; 25(2):137-41. PubMed ID: 15900986
[TBL] [Abstract][Full Text] [Related]
20. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
Messing EM; Albertsen P; Andriole GL; Carroll PR; Klein EA
Urol Oncol; 2012; 30(1):117-9. PubMed ID: 22243597
[No Abstract] [Full Text] [Related]
[Next] [New Search]
